Putnam Investments’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Putnam Investments’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-20,488	Closed	-$388K	–	1320
2016 Q4	$388K	Buy	20,488 +307	+2%	+$5.89K	﹤0.01%	1155
2016 Q3	$447K	Sell	20,181 -27,031	-57%	-$508K	﹤0.01%	1140
2016 Q2	$863K	Sell	47,212 -963	-2%	-$16.6K	﹤0.01%	1125
2016 Q1	$876K	Buy	48,175 +1,014	+2%	+$16.4K	﹤0.01%	1138
2015 Q4	$795K	Sell	47,161 -713	-1%	-$12.1K	﹤0.01%	1205
2015 Q3	$863K	Buy	47,874 +1,518	+3%	+$33.8K	﹤0.01%	1205
2015 Q2	$1.2M	Buy	+46,356	New	+$1.17M	﹤0.01%	1185

Other funds holding ENTL

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

DGI

Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Putnam Investments's ENTL Position: Q1 2017 in Review

Putnam Investments sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2017, closing a stake of 20,488 shares — an estimated $388K sold.

Putnam Investments first reported a position in ENTL in Q2 2015 and held it in 7 quarters. The position peaked at $1.2M in Q2 2015. 69 funds tracked by Wall St. Rank hold ENTL as of Q1 2017.

Putnam Investments reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
Putnam Investments sold 20,488 Entellus Medical, Inc. Common Stock shares in Q1 2017, an estimated $388K.
Putnam Investments first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
Putnam Investments's Entellus Medical, Inc. Common Stock position peaked at $1.2M in Q2 2015.
69 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.